HOME >> BIOLOGY >> NEWS
Scientist honored with second-most cited research paper of the decade

Wladek Minor's busy laboratory inside Jordan Hall at the University of Virginia Health System is famous for strong cappuccino and European chocolates. But now there's something a lot bigger to crow about- the esteem of his competitive scientific colleagues around the world.

A professor of molecular physiology and biological physics and a native of Poland, Minor is a pioneer in the growing field of protein crystallography. His lab's work is not going unnoticed. A 1997 paper, "Processing of X-ray Differentiation Data Collected in Oscillation Mode," published with Zbyszek Otwinowski, a colleague at the University of Texas, is now the second-most cited scientific paper in the world in the last ten years, according to The Scientist magazine. The title may glaze the eyes of a layman, but the discovery is a building block of science and may one day help doctors treat cancer patients or people with viruses. "We are trying to elucidate the 3-dimensional structure of protein molecules which will hopefully lead to new cures for a host of diseases," Minor said.

Inside the Minor lab, a joyful polyglot of languages- Polish, Chinese, English- fills the air, usually seven days a week, amid chemical bottles, beakers, machines and microscopes. Minor's scientists use personal digital assistants (PDA's) connected to a central server to track all their experiments.

Minor and his ambitious team are tearing apart tiny proteins, trying to figure out the relationship between their structure and function. Their goal is to solve one of the greatest mysteries in intelligent drug design- how specific, targeted drugs can kill viruses or cancer cells by finding their way around the human body's complex chemistry and innumerable defenses.

The 1997 paper describes a computer program used to process the data coming from X-ray experiments made on protein crystals. The program is now used in over 1,200 laboratories worldwide and has been improved over the years. Mino
'"/>

Contact: Bob Beard
bobbeard@virginia.edu
434-982-4490
University of Virginia Health System
17-Jan-2006


Page: 1 2

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. Scientists prove that disputed Korean stem cell line comes from an unfertilized egg and not cloning
3. Scientists move closer to bio-engineered bladders
4. Scientists find stem cell switch
5. Scientists discover new way to study nanostructures
6. Scientists a step closer to understanding how anaesthetics work in the brain
7. Scientists to make news at Computational Biology Conference
8. Accident-prone? Scientists link brain function to knee injuries
9. Scientists take next step in understanding potential target for ovarian cancer treatment
10. Scientists find brown fat master switch
11. Scientists identify 2 distinct Parkinsons networks

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scientist honored with second most cited research paper the decade

(Date:10/15/2014)... , Oct. 15, 2014 Sandata Technologies, ... home and community-based care, today announced it released ... Sandata,s Santrax® Electronic Visit Verification™ Solution (EVV™)  for ... a home health company founded in 1996 and ... . The study details the ...
(Date:10/15/2014)... linked increased resistance to bacterial pneumonia in female mice ... estrogen. , Females are naturally more resistant to respiratory ... has shown that increased resistance to bacterial pneumonia in ... synthase 3 (NOS3). They also show that this enzyme ... sex hormone estrogen. , The team, lead by Professor ...
(Date:10/14/2014)... Cancer Research shows SIRT6—a protein known to ... the development of skin cancers by turning on an ... skin cells. , Previously considered protective, SIRT6 is part ... help regulate genomic stability and prevent some of the ... damage, which can lead to cancer. This study, in ...
Breaking Biology News(10 mins):Sandata Announces Case Study with Quality Care Services, Inc. 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2
(Date:10/25/2014)... October 24, 2014 Today, Nerium International, ... the winners of its “Reflect Your Youth” contest, an ... only seen a difference in their skin since using ... new outlook on life as a result of their ... as an effort by Nerium International to inspire conversations ...
(Date:10/25/2014)... , October 24, 2014 ... clinical-stage pharmaceutical company focused on the development of oral ... Nadav Kidron will present at FireRock Capital,s ... Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, 2014 ... New York City , ...
(Date:10/25/2014)... 2014 Research and Markets has ... Product , Research Area & by End User - ... In this report, the global epigenetics ... areas, and end users. The product segments of the ... & consumables, kits, and reagents. The subsegments of the ...
(Date:10/22/2014)... DUBLIN and BOSTON , ... ACT ), a leading global specialty pharmaceutical company, and ... been granted an exclusive option to acquire Rhythm,s wholly ... (RM-131), a peptide ghrelin agonist, for the treatment of ... Rhythm has completed a successful Phase 2 trial ...
Breaking Biology Technology:Nerium International™ Inspires Conversation About the Journey of Aging with “Reflect Your Youth” Contest 2Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5
Cached News: